Boutique Investment Bank & Strategic Advisor

Advisors to Emerging Healthcare Technology Startups.

Match Point Partners is a boutique investment bank and strategic advisory firm specializing in healthcare technology companies. Founded in 2009 and headquartered in New York City, we have completed more than 150 engagements for venture- and growth-stage companies across the U.S. and in more than 15 countries around the world.

The Firm at a Glance
Founded2009
Engagements150+
HeadquartersNew York City
FocusHealthcare Tech
The Firm

Match Point Partners is a boutique investment bank and strategic advisory firm for healthcare technology companies — combining banking expertise with hands-on operating experience.

Our services span four core practice areas: mergers and acquisitions (M&A) advisory, fundraising advisory for venture and growth-stage companies, operational and executive restructuring, and strategic planning. Our team combines former C-suite operators from private equity- and venture-backed firms, investment bankers, and experienced entrepreneurs — a multidisciplinary approach that produces measurably better outcomes for clients navigating critical inflection points.

Founded2009
HeadquartersNew York City, NY
Engagements completed150+
Core servicesM&A, Fundraising, Restructuring, Strategy
SectorsHealthcare IT, Digital Health, MedTech, Health Technology, SaaS, Enterprise Software
Client stageVenture and growth-stage
Geographic reachU.S. & 15+ countries internationally
Broker-dealerINTE Securities LLC · FINRA/SIPC
Suite of Services

Four integrated practices.

Match Point Partners offers four integrated service lines for healthcare technology companies.

01 / Capital

Fundraising Advisory

We advise venture-stage and growth-stage companies on equity capital raises from seed through Series C and beyond. Our engagements include story refinement, investor targeting, materials preparation, process management, and term negotiation. We have advised on fundraises ranging from early-stage seed rounds to growth equity transactions valued in the tens of millions of dollars, with investors including venture capital firms, corporate strategics, and private equity funds.

02 / M&A

Mergers & Acquisitions Advisory

We provide sell-side advisory, buy-side advisory, and corporate divestitures for healthcare technology companies. Our sell-side engagements include full auction processes and targeted buyer outreach. Our buy-side work includes target identification, valuation, and negotiation support. Representative acquirers and strategic partners in our transaction history include IQVIA, Accolade, Fabric, Clinigen, HMP Global, and others.

03 / Operations

Restructuring & Interim Executives

We provide drop-in C-suite operating executives — including interim CEOs, CFOs, and CTOs — to companies in transition, typically for engagements of three to eighteen months. We also advise companies navigating financial stress or strategic repositioning, helping leadership evaluate options, build stakeholder consensus, and execute a chosen path. Our operating partners have held C-suite roles at venture- and private equity-backed firms across the healthcare technology sector.

04 / Strategy

Strategic Advisory

Our strategic advisory practice covers industry landscape reviews, competitive analysis, go-to-market strategy, pricing model development, technology assessment, and team structure planning. We work with healthcare technology companies at inflection points — pre-raise, pre-sale, post-acquisition, or entering a new market. We have conducted strategic landscape reviews for large pharma and healthcare organizations including Pfizer, Satellite Healthcare, Bristol-Myers Squibb, and NEVRO. Sales strategy and customer positioning services are also available.

Our Approach

A disciplined process, applied to every engagement.

Match Point Partners follows a disciplined, four-stage advisory process designed to maximize value for clients at each step.

01

Diagnostic Review

We begin by listening. Before designing any plan, we conduct a comprehensive review of the client's business model, financial position, market dynamics, and competitive landscape. This phase surfaces the true challenge — which is often distinct from the presenting issue.

02

Strategic Plan Development

We design a customized strategy and gain leadership consensus before moving to execution. Because no two clients face identical situations, we do not apply templated solutions — our integrated team draws on operating experience, financial expertise, and sector knowledge.

03

Execution

We work alongside management teams to implement the agreed plan — whether that means running a full M&A sale process, managing a fundraising roadshow, placing interim executives, or driving a strategic repositioning. We are hands-on participants, not observers.

04

Post-Transaction Support

Transactions and restructurings create new challenges. We remain available to clients after deal close or project completion to assist with integration planning, leadership transitions, and strategic follow-through.

Representative Transactions

The track record speaks first.

A selection of completed M&A, fundraising, and strategic advisory engagements. Match Point Partners has completed more than 150 engagements since its founding in 2009, serving clients across healthcare technology, digital health, pharma services, MedTech, SaaS, and life sciences.

whiz.ai
Pharma Services AI
IQVIA acquired whiz.ai
2025M&A — Sell-Side
UCM Digital Health
Telehealth
Fabric acquired UCM Digital Health
2025M&A — Sell-Side
Wizard Software
Health Tech
Northrim Horizon acquired Wizard Software
2024M&A — Sell-Side
Ascenian
Pharma Access
Sale of company to Clinigen
2024M&A — Sell-Side
Donor Concierge
In Vitro Platform Services
Northstar acquired Donor Concierge
2023M&A — Sell-Side
Microhealth
Specialty Pharma Tech
Top 5 Pharma invested
2023Financing
HealthEC
Population Health Platform
Labcorp and current investors recapitalized HealthEC
2023Recapitalization
HealthXL
Expert Network
HLTH acquired HealthXL
2023M&A — Sell-Side
NEVRO
Pharma Services
Strategic assignment — M&A landscape review
2022Strategic Advisory
Complion
Digital Clinical Trials
Real Time/LLR acquired Complion
2022M&A — Sell-Side
Proximity Health
Oncology Market Access
HMP Global acquired Proximity Health
2022M&A — Sell-Side
Kaden Health
Behavioral Health
Sale of company to BayMark Health Services
2022M&A — Sell-Side
HealthReveal
Diagnostics AI
Sale of company to Accolade
2021M&A — Sell-Side
Inteliquet
Oncology Data / RWD
Sale of company to IQVIA
2021M&A — Sell-Side
Bristol-Myers Squibb
Pharma / Life Sciences
Strategic assignment — sector analysis
2021Strategic Advisory
Apervita (Qcentive Division)
Healthcare Analytics
Sale of Qcentive division to Clarify Health
2021M&A — Divestiture
Cureatr
Medication Management
Series B equity fundraise
2021Fundraising — Series B
Oculo
Ophthalmology / MedTech
Sale of company to Revenio Group
2021M&A — Sell-Side
Kaden Health
Behavioral Health
Series A equity raise from Magellan Health
2020Fundraising — Series A
Arterys
Medical Imaging AI
$27M Series C equity raise
2020Fundraising — Series C
KAI Research
Clinical Research
Acquisition by Navitas Life Sciences
2019M&A — Sell-Side
DoseMe
Precision Dosing
Acquisition by Tabula Rasa HealthCare
2019M&A — Sell-Side
Satellite Healthcare
Dialysis Services
Strategic assignment — CKD startup landscape review
2019Strategic Advisory
Pfizer
Pharma
Strategic assignment — Sleep Tech startup landscape review
2018Strategic Advisory
Apervita
Healthcare Analytics
Optum Ventures investment
2017Fundraising
Ametros Financial
Healthcare Finance
Growth capital from Long Ridge Equity Partners
2017Fundraising

Match Point Partners has completed more than 150 total engagements. The transactions above are representative and publicly disclosed. Additional engagements are available upon request.

Global Experience

Helping international companies enter U.S. markets.

Match Point Partners has been retained by companies based in Europe, Latin and South America, Canada, and Israel seeking to enter or expand within the U.S. healthcare technology market. We maintain active relationships with international corporate strategics and private equity funds with cross-border mandates, enabling us to connect clients with capital and partnership opportunities across geographies.

  • 01Raising capital from U.S.-based venture capital, growth equity, or strategic investors
  • 02Identifying and securing the firm's first U.S. commercial clients
  • 03Completing an anchor U.S. acquisition to establish a domestic footprint
  • 04Accessing U.S. healthcare market expertise and regulatory knowledge
Our Team

Operators, bankers, and entrepreneurs.

Senior practitioners who have built, financed, and led healthcare technology companies.

Bradford C. Burkett

Bradford C. Burkett

Managing Partner

Founder and Managing Partner; established the firm in 2009. More than 30 years advising healthcare technology companies on M&A, capital formation, and strategic transformation. An eight-time CEO in healthcare, technology, and business services, Brad has led over 200 transactions worth more than $2.5 billion in value.

LinkedIn
Jody Holtzman

Jody Holtzman

Managing Director

Strategy and advisory engagements across healthcare and aging services. Deep expertise in health technology, consumer health, and the longevity economy, with senior leadership roles at AARP and other healthcare organizations. Advises on market positioning, product strategy, and go-to-market execution.

LinkedIn
Joe F. Edwards

Joe F. Edwards

Managing Director

M&A and strategic advisory across healthcare technology and life sciences, with transaction and operating experience from prior roles in investment banking and corporate strategy. Advises on sell-side and buy-side M&A processes, partnership structuring, and strategic planning.

Jan Barker

Jan Barker

Managing Director

Healthcare IT and digital health advisory, with an extensive background including senior executive and advisory roles at health systems, payers, and technology companies. Advises clients on market strategy, customer development, and commercial positioning.

LinkedIn
Hans Kastensmith

Hans Kastensmith

Operating Partner

Senior operating leadership for the firm's interim executive and operational restructuring practice. Has served in C-suite roles at technology and healthcare companies, with expertise in business development, operations, and enterprise growth.

Al Holmes

Al Holmes

Chief Technology Officer

Serves as CTO and is available as an interim CTO to clients. Deep technical expertise in software architecture, product development, and technology strategy, with prior CTO experience at healthcare and technology companies. Advises on technology assessment, digital transformation, and technical due diligence.

LinkedIn
Peter Kase

Peter Kase

Chief Financial Officer

Serves as CFO and is available as an interim CFO to clients. Broad financial leadership experience including financial planning and analysis, capital structure optimization, and transaction financial management. Supports fundraising materials, financial modeling, and CFO-level operational leadership.

Frequently Asked Questions

What people ask about Match Point Partners.

Match Point Partners is a boutique investment bank and strategic advisory firm that helps healthcare technology companies raise capital, complete mergers and acquisitions, restructure operations, and develop growth strategies. Founded in 2009, the firm has completed more than 150 engagements for venture- and growth-stage companies.

Match Point Partners primarily works with companies in healthcare technology, digital health, pharma services, MedTech, SaaS, and life sciences — with a singular focus on healthcare startups and growth-stage companies. Clients range from early-stage venture-backed startups raising their first institutional round to growth-stage companies pursuing M&A exits or strategic partnerships.

Match Point Partners provides sell-side M&A advisory (helping companies find and negotiate with acquirers), buy-side M&A advisory (helping companies identify and acquire targets), and corporate divestitures. The firm manages full transaction processes including buyer or investor identification, valuation, negotiation, and deal execution. Recent acquirers in Match Point transactions include IQVIA, Fabric, Clinigen, Accolade, and HMP Global.

Match Point Partners advises on a range of transaction sizes, typically working with venture-stage and growth-stage companies. Fundraising engagements have ranged from early-stage seed rounds to growth equity transactions. M&A transactions have included strategic sales to large healthcare and technology acquirers including IQVIA, Accolade, Tabula Rasa HealthCare, and Revenio Group.

Yes. Match Point Partners has advised companies based in Europe, Latin and South America, Canada, and Israel seeking to access U.S. markets, with experience across more than 15 countries. International engagements typically involve U.S. capital raises, entry-level U.S. commercial client development, or anchor U.S. acquisitions.

Yes. Through its operational restructuring and interim executive placement practice, Match Point Partners can provide experienced interim CEOs, CFOs, and CTOs to companies in transition. Typical engagements run three to eighteen months.

Match Point Partners is headquartered in New York City at 125 Park Avenue, Suite 2500, New York, NY 10017.

Match Point Partners was founded in 2009 and has been operating for more than 17 years. The firm has completed more than 150 advisory engagements across M&A, fundraising, operational restructuring, and strategic advisory practices.

Match Point Partners was founded in 2009 by Bradford C. Burkett, who serves as Managing Partner. Brad is an eight-time CEO in healthcare, technology, and business services, with more than 30 years of experience and over 200 transactions worth more than $2.5 billion in value.

Match Point Partners differentiates itself through a combination of investment banking expertise, hands-on operating experience, and a singular focus on healthcare startups and growth-stage companies. The team includes former C-suite executives from venture- and private equity-backed companies who bring practical operating knowledge alongside transaction advisory skills. This allows the firm to assist clients not just in completing transactions, but in positioning themselves for success before, during, and after a deal.

All securities transactions are effected through INTE Securities LLC, a registered broker-dealer and member of FINRA (finra.org) and SIPC (sipc.org). INTE Securities LLC can be viewed along with their form CRS at finra.org/brokercheck.

Contact

Start a conversation.

To discuss an engagement, explore a transaction, or learn more about our services, please reach out to our team. We serve clients in the healthcare technology sector worldwide.

NYC · HQ

New York City

125 Park Avenue, Suite 2500
New York, NY 10017

Send us a note

Tell us about your company and what you're working toward.

Email Brad Burkett →